D. Boral Capital Reaffirms Buy Rating for Coya Therapeutics (NASDAQ:COYA)
Coya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating restated by research analysts at D. Boral Capital in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $18.00 price target on the stock. D. Boral Capital’s price target suggests a potential upside of 174.39% from the […]
Coya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating restated by research analysts at D. Boral Capital in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $18.00 price target on the stock. D. Boral Capital’s price target suggests a potential upside of 174.39% from the […]
